Australian retail giant Chemist Warehouse is going head on with its competition.

EDs seeing new wave of ultra-potent synthetic drugs are being invited to join new effort.

One of Auckland university's more than a dozen drugs to have reached clinical trial stage.

Patients say they're suffering over Pharmac's move to cheaper, generic anti-depressant.

Abortion committee urges politicians to update "archaic" law.

It's been a year and no decision has been made on funding for cancer drug Keytruda.

A new pharmacy has taken an unusual approach to increased competition.

Australian firm Life-Space, managed by Kiwi Craig Silbery, has been sold for A$690 million

A pharmacist sold large amounts of addictive drugs to people without prescriptions.

The most hated man in America is selling the one-of-a-kind Wu-Tang album.

Medical cannabis campaigner Rose Renton was behind the rat poison protest.

Whether investors were actually defrauded has emerged as a central theme in his trial.

Defence paints Martin Shkreli as 'odd' but also an investing 'genius'.

The latest on the fraud trial of Martin "Pharma Bro" Shkreli.

Researchers call for urgent action over an antipsychotic drug linked to 13 NZ deaths.

NZ scientists have made a surprise genetic finding that could help combat drug resistance.

The world's next big antibiotic could lie hidden in our native fungi.

Doctors are on the cusp of launching the first new male contraceptive.

AFT Pharmaceuticals expects annual sales to meet analysts' forecasts of about $70 million.

Doctors have expressed concern that the changes could undermine the relationship between women and their GPs.

A protein may be the key to unlocking a regular, healthy circadian rhythm no matter where (or when) in the world you are.

A drug company that made a $34,000-a-vial medicing has agreed to pay $100 million to settle a lawsuit alleging preventing competition.

Outspoken former pharmaceutical executive Martin Shkreli said the national outrage over drug pricing was blown out of proportion.

Pharmac announced today it would start funding the breast cancer drug Perjeta, but 160 Kiwis who have already started treatment won't be eligible.

AFT Pharmaceuticals widened its first-half loss after ramping up R&D and launching over-the-counter products in Australia and Singapore.

Kiwi experts are on the front lines fighting the "antibiotic apocalypse".

A major medical marijuana trial is underway in New Zealand - testing the effects of a new cannabis gel on epilepsy patients.

As a nationwide opioid epidemic raged, DEA investigators went after companies distributing millions of highly addictive pills. Then, their cases ground to a halt.

Douglas Pharmaceuticals expects the US market to become its biggest, overtaking the EU in the near future.

NZ Cancer Society medical director Dr Christopher Jackson discusses urgent worries around New Zealand's systems for reviewing and funding ground-breaking new cancer drugs.